JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases.

Front Med (Lausanne) · 2023 · PMC10017532 · PMID 36936239

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Differences versus placebo did not reach statistical significance beyond this period.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.